Flex Pharma (FLKS) Tops Q1 EPS by 3c

Flex Pharma (NASDAQ: FLKS) reported Q1 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $179 thousand versus the consensus estimate of $280 thousand.

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c